MedTrace Logo

OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarction (OPTIMAL)

NCT03084991 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4500

Last updated 2021-06-09

No results posted yet for this study

Summary

The purpose of the study is to investigate the clinical outcomes, safety and cost-effectiveness of intravascular OCT imaging in patients with acute myocardial infarction undergoing percutaneous coronary intervention (PCI). About 4500 patients with acute myocardial infarction (estimated 1500 with OCT guidance and 3000 without OCT guidance during PCI）will be prospectively enrolled in 20 sites in China. The total duration of the study is expected to be 5 years, 2 years for enrolment and 3 years for follow up.

Conditions

  • Acute Myocardial Infarction

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Harbin Medical University

    lead OTHER

Principal Investigators

  • Bo Yu, MD,PhD · The Second Affiliated Hospital of Harbin Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-17
Primary Completion
2021-07-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03084991 on ClinicalTrials.gov